Novel antibiotics in the fight against antimicrobial resistance
SANTERO announces a €8 million Series A funding round led by Newton Biocapital
12-Jun-2023 -
Newton Biocapital (NBC), a venture capital firm focused on investing and growing early-stage life sciences companies in Europe and Japan targeting chronic health conditions, has announced the closing of a successful €8 million Series A financing round for Santero.
SANTERO, a spin-off company of ...
antibiotic resistance
antibiotics
antimicrobial drugs
+7